CSC Pharmaceuticals International

Gamdevi, Mumbai, Maharashtra

As a renowned Exporter, we bring forth a wide variety of Pharmaceutical Syrups which are used for curing various ailments. These Pharmaceutical Syrups include syrups for treating ailments like cough, vomiting, etc. Our range of Pharmaceutical Syrups is available in tamper-proof packaging so as to ensure zero contamination. Further, our Pharmaceutical Syrups are also valued for their accurate composition, purity, long shelf life and zero side effects. Owing to these features, our Pharmaceutical Syrups are widely demanded by pharmaceutical industry.

We offer the following Pharmaceutical Syrups :

• Cristarox dry syrup : Each 5ml after reconstitution consists of cefuroxime axetil u. S. P equivalent to cefuroxime 125 mg
• Vomitron syrup : Each 5ml contains ondansetron dihydrochloride equivalent to ondansetron u. S. P 2mg. Its colors are sunset yellow and carmoisine
• Cristaclor oral suspension : Each 5 ml after reconstitution contains cefaclor u. S. P: 125 mg/5 ml
• Curox 30 ml oral suspensions : Each 5ml contains ofloxacin u. S. P 50mg in flavored syrup

Lapatinib is a small molecule and a member of the 4-anilinoquinazoline class of kinase inhibitors. It is present as the monohydrate of the ditosylate salt, with chemical name N-(3- chloro-4-[(3-fluorophenyl)methyl]oxyphenyl)-6-[5-([2- (methylsulfonyl)ethyl]aminomethyl)-2-furanyl]-4-quinazolinamine bis(4- methylbenzenesulfonate) monohydrate. It has the molecular formula C29H26ClFN4O4S (C7H8O3S)2 H2O and a molecular weight of 943.5. Lapatinib ditosylate monohydrate has the following chemical structure:
TYKERB (lapatinib) Structural Formula Illustration
Lapatinib is a yellow solid, and its solubility in water is 0.007 mg/mL and in 0.1N HCl is 0.001 mg/mL at 25°C.
Each 250 mg tablet of TYKERB contains 405 mg of lapatinib ditosylate monohydrate, equivalent to 398 mg of lapatinib ditosylate or 250 mg lapatinib free base.
The inactive ingredients of TYKERB are: Tablet Core: Magnesium stearate, microcrystalline cellulose, povidone, sodium starch glycolate. Coating: Orange film-coat: FD&C yellow No. 6/sunset yellow FCF aluminum lake, hypromellose, macrogol/PEG 400, polysorbate 80, titanium dioxid

Treatment of metastatic bone disease, to reduce the risk of skeletal complications of malignant disease eg hypercalcemia, pain, the need for radiotherapy against painful bone lesions & impending fractures & decrease the risk for fractures.Should be taken on an empty stomach. (Must be taken at least 1 hr before the 1st food, drink or medication of the day. Take w/ a full glass of only plain water upon arising for the day & remain in sitting/upright position for at least 1 hr. Do not lie down, eat/drink anything except plain water or take other oral medicines for at least 1 hr. Swallow whole, do not chew/crush/suck.)